Literature DB >> 28894322

Implications of Changes to the Mefloquine Product Monograph.

Remington L Nevin1.   

Abstract

Entities:  

Year:  2017        PMID： 28894322      PMCID： PMC5587051          DOI： 10.4212/cjhp.v70i4.1687

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN： 0008-4123


× No keyword cloud information.
  4 in total

1.  2004 Canadian recommendations for the prevention and treatment of malaria among international travellers.

Authors: 
Journal:  Can Commun Dis Rep       Date:  2004-06

2.  Mefloquine dangers - fact or fancy?

Authors:  J Keystone; K Kain
Journal:  Can J Infect Dis       Date:  1995-01

3.  Neuropsychiatric side effects of mefloquine.

Authors:  D Stürchler; J Handschin; D Kaiser; L Kerr; M L Mittelholzer; R Reber; M Fernex
Journal:  N Engl J Med       Date:  1990-06-14       Impact factor: 91.245

4.  Neuropsychiatric Adverse Reactions to Mefloquine: a Systematic Comparison of Prescribing and Patient Safety Guidance in the US, UK, Ireland, Australia, New Zealand, and Canada.

Authors:  Remington L Nevin; Aricia M Byrd
Journal:  Neurol Ther       Date:  2016-05-30
  4 in total
  1 in total

1.  A serious nightmare: psychiatric and neurologic adverse reactions to mefloquine are serious adverse reactions.

Authors:  Remington L Nevin
Journal:  Pharmacol Res Perspect       Date:  2017-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.